Means Investment Co., Inc. Bristol Myers Squibb CO Transaction History

Means Investment Co., Inc.

$882 Million
Q3 2024

A detailed history of Means Investment Co., Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Means Investment Co., Inc. holds 29,149 shares of BMY stock, worth $1.72 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

29,149

Previous 32,546 10.44%

Holding current value

$1.72 Million

Previous $1.35 Million 11.62%

% of portfolio

0.17%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$39.66 - $51.75 $134,725 - $175,794	-3,397 Reduced 10.44%	29,149 $1.51 Million
Q2 2024 Jul 19, 2024	SELL	$40.25 - $52.99 $53,572 - $70,529	-1,331 Reduced 3.93%	32,546 $1.35 Million
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $336,675 - $381,724	-7,017 Reduced 17.16%	33,877 $1.84 Million
Q4 2023 Jan 25, 2024	SELL	$48.48 - $57.85 $481,842 - $574,971	-9,939 Reduced 19.55%	40,894 $2.1 Million
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $256,742 - $287,077	-4,435 Reduced 8.02%	50,833 $2.95 Million
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $59,759 - $66,354	938 Added 1.73%	55,268 $3.53 Million
Q1 2023 May 08, 2023	SELL	$65.71 - $74.53 $1,182 - $1,341	-18 Reduced 0.03%	54,330 $3.77 Million
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $25,474 - $30,165	-372 Reduced 0.68%	54,348 $0
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $33 - $19,747	257 Added 0.47%	54,720 $3.89 Million
Q2 2022 Jul 21, 2022	BUY	$72.62 - $79.98 $34,131 - $37,590	470 Added 0.87%	54,463 $4.19 Million
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $1,905 - $2,285	-31 Reduced 0.06%	53,993 $3.94 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $16,249 - $18,943	303 Added 0.56%	54,024 $3.37 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $161,001 - $188,592	2,721 Added 5.34%	53,721 $3.18 Million
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $18,263 - $19,888	-295 Reduced 0.58%	51,000 $3.41 Million
Q1 2021 Apr 05, 2021	SELL	$59.34 - $66.74 $192,024 - $215,970	-3,236 Reduced 5.93%	51,295 $3.24 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $4,388 - $4,972	76 Added 0.14%	54,531 $3.27 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $51,629 - $57,212	-899 Reduced 1.62%	54,455 $3.47 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $22,037 - $25,764	402 Added 0.73%	55,354 $3.49 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $92,846 - $134,927	-2,001 Reduced 3.51%	54,952 $3.35 Million
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $443,775 - $578,865	9,018 Added 18.81%	56,953 $3.8 Million
Q3 2019 Nov 05, 2019	BUY	$42.77 - $50.71 $37,380 - $44,320	874 Added 1.86%	47,935 $2.72 Million
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $71,972 - $79,585	-1,613 Reduced 3.31%	47,061 $2.17 Million
Q1 2019 Apr 16, 2019	BUY	$45.12 - $53.8 $213,282 - $254,312	4,727 Added 10.76%	48,674 $2.32 Million
Q4 2018 Apr 16, 2019	BUY	$48.76 - $63.23 $2.14 Million - $2.78 Million	43,947 New	43,947 $2.28 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.

Account

Means Investment Co., Inc. Bristol Myers Squibb CO Transaction History